Invesco Ltd. Athersys, Inc Transaction History

Invesco Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.18 - $0.86 $12,124 - $57,929	-67,360 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.6 - $1.06 $890 - $1,573	-1,484 Reduced 2.16%	67,360 $41,000
Q4 2021 Feb 14, 2022	SELL	$0.85 - $1.4 $16,800 - $27,671	-19,765 Reduced 22.31%	68,844 $62,000
Q3 2021 Nov 15, 2021	BUY	$1.33 - $1.77 $22,707 - $30,219	17,073 Added 23.87%	88,609 $118,000
Q2 2021 Aug 17, 2021	BUY	$1.41 - $1.94 $32,372 - $44,540	22,959 Added 47.26%	71,536 $102,000
Q1 2021 May 17, 2021	BUY	$1.61 - $2.77 $26,157 - $45,004	16,247 Added 50.25%	48,577 $88,000
Q4 2020 Feb 16, 2021	BUY	$1.55 - $2.24 $50,111 - $72,419	32,330 New	32,330 $57,000

Ticker ATHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 305,110,016
Market Cap $3.05M
Description
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.